Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Wigerup

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Scientific Reports|September 2, 2017
Neuroblastoma patient-derived xenograft cells cultured in stem-cell promoting medium retain tumorigenic and metastatic capacities but differentiate in serumCamilla U Persson, Kristoffer von Stedingk, Daniel Bexell, et al.
Oncotarget|February 6, 2016
HIF2α contributes to antiestrogen resistance via positive bilateral crosstalk with EGFR in breast cancer cellsMuhammad Wasi Alam, Camilla Ulrika Persson, Susann Reinbothe, et al.
EMBO Reports|July 24, 2010
Acetylation-dependent oncogenic activity of metastasis-associated protein 1 co-regulatorKazufumi Ohshiro, Suresh K Rayala, Caroline Wigerup, et al.
International Journal of Cancer|September 16, 2014
Neuroblastoma patient-derived orthotopic xenografts retain metastatic patterns and geno- and phenotypes of patient tumoursNoémie Braekeveldt, Caroline Wigerup, David Gisselsson, et al.
Cancer Letters|March 23, 2016
Neuroblastoma patient-derived orthotopic xenografts reflect the microenvironmental hallmarks of aggressive patient tumoursNoémie Braekeveldt, Caroline Wigerup, Irene Tadeo, et al.
Cell Reports|August 10, 2022
Phosphoproteomics of primary AML patient samples reveals rationale for AKT combination therapy and p53 context to overcome selinexor resistanceKristina B Emdal, Nicolàs Palacio-Escat, Caroline Wigerup, et al.
Oncogene|December 13, 2018
ALK positively regulates MYCN activity through repression of HBP1 expressionShana Claeys, Geertrui Denecker, Kaat Durinck, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Scientific Reports|September 2, 2017
Neuroblastoma patient-derived xenograft cells cultured in stem-cell promoting medium retain tumorigenic and metastatic capacities but differentiate in serumCamilla U Persson, Kristoffer von Stedingk, Daniel Bexell, et al.
Oncotarget|February 6, 2016
HIF2α contributes to antiestrogen resistance via positive bilateral crosstalk with EGFR in breast cancer cellsMuhammad Wasi Alam, Camilla Ulrika Persson, Susann Reinbothe, et al.
EMBO Reports|July 24, 2010
Acetylation-dependent oncogenic activity of metastasis-associated protein 1 co-regulatorKazufumi Ohshiro, Suresh K Rayala, Caroline Wigerup, et al.
International Journal of Cancer|September 16, 2014
Neuroblastoma patient-derived orthotopic xenografts retain metastatic patterns and geno- and phenotypes of patient tumoursNoémie Braekeveldt, Caroline Wigerup, David Gisselsson, et al.
Cancer Letters|March 23, 2016
Neuroblastoma patient-derived orthotopic xenografts reflect the microenvironmental hallmarks of aggressive patient tumoursNoémie Braekeveldt, Caroline Wigerup, Irene Tadeo, et al.
Cell Reports|August 10, 2022
Phosphoproteomics of primary AML patient samples reveals rationale for AKT combination therapy and p53 context to overcome selinexor resistanceKristina B Emdal, Nicolàs Palacio-Escat, Caroline Wigerup, et al.
Oncogene|December 13, 2018
ALK positively regulates MYCN activity through repression of HBP1 expressionShana Claeys, Geertrui Denecker, Kaat Durinck, et al.
Pageof 2